Author

Alina Zorn

University of GlasgowORCID 0000-0001-5267-0514Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Alina Zorn1 paper · University of Glasgow;

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Bria O’Gorman· 1 shared Chih-Jung Chang· 1 shared Connor M. BlairiD· 1 shared Danny T. Huang· 1 shared Elka KyurkchievaiD· 1 shared George S. Baillie· 1 shared Gillian Lappin· 1 shared Helen WheadoniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bria O’Gorman

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyMolecular Therapy OncologyPeer-reviewedAug 6, 2025

Targeting MDM2 homodimer and heterodimer disruption with DRx-098D in TP53 wild-type and mutant cancer cells

Sean F Cooke, Thomas A. Wright, Gillian Lappin…·Connor M. Blair

This study shows DRx-098D, a peptide disrupting MDM2 dimerisation, effectively inhibits cancer cell growth in TP53 wild-type and mutant cell lines, outperforming Idasanutlin in TP53 null cells.

2 citations

humanexperimental assay

𝕏 PostBluesky